Drug Guide
Colesevelam Hydrochloride
Classification
Therapeutic: Lipid-lowering agent
Pharmacological: Bile acid sequestrant
FDA Approved Indications
- Type 2 diabetes mellitus (adjunct to diet and exercise)
- Primary hyperlipidemia (combination or monotherapy)
Mechanism of Action
Bile acid sequestrant that binds bile acids in the intestine, preventing their reabsorption. This leads to increased conversion of cholesterol into bile acids in the liver, thereby reducing LDL cholesterol levels.
Dosage and Administration
Adult: 8 g daily in divided doses or 3.75 g twice daily with meals
Pediatric: Not approved for children; use outside specified age groups only as directed by a healthcare provider
Geriatric: No specific dosage adjustment required, but monitor for constipation and other side effects
Renal Impairment: No adjustment recommended; use caution
Hepatic Impairment: Use with caution; no specific dosage adjustment established
Pharmacokinetics
Absorption: Minimal systemic absorption
Distribution: Not extensively distributed systemically
Metabolism: Not metabolized appreciably, excreted largely unchanged
Excretion: Excreted in feces
Half Life: Not well-defined due to minimal systemic absorption
Contraindications
- Bowel obstruction
- History of hypersensitivity to colesevelam
Precautions
- Monitor for constipation and gastrointestinal side effects
- Use cautiously in patients with triglyceride levels >500 mg/dL
- Can interfere with absorption of fat-soluble vitamins
Adverse Reactions - Common
- Constipation (Common)
- Nausea (Common)
- Disphagia (Less common)
Adverse Reactions - Serious
- Elevated triglycerides (Less common)
- Bowel obstruction (Rare)
Drug-Drug Interactions
- May reduce absorption of oral medications and vitamins; separate dosing by 4 hours
- Thyroid hormone replacement
- Fat-soluble vitamin supplements
Drug-Food Interactions
N/ADrug-Herb Interactions
N/ANursing Implications
Assessment: Monitor lipid levels, bowel function, triglycerides, and vitamin levels
Diagnoses:
- Risk for constipation
- Ineffective health management
Implementation: Administer with meals; educate about dietary fiber intake
Evaluation: Assess lipid panel response, gastrointestinal tolerance, and vitamin levels
Patient/Family Teaching
- Take medication with meals as directed
- Increase dietary fiber and fluid intake to prevent constipation
- Report persistent gastrointestinal symptoms or signs of vitamin deficiency
- Inform healthcare provider about all medications and supplements
Special Considerations
Black Box Warnings: N/A
Genetic Factors: No known genetic considerations
Lab Test Interference: May interfere with some laboratory tests (e.g., fat-soluble vitamin levels)
Overdose Management
Signs/Symptoms: Potential gastrointestinal discomfort, constipation
Treatment: Supportive care; no specific antidote
Storage and Handling
Storage: Store at room temperature away from moisture and heat
Stability: Stable under recommended storage conditions